Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Biogen Inc. Receives Multiple Analyst Downgrades, Market Reacts Coolly - Simply Wall St News

December 28, 2024
Biogen Inc., a leading biotechnology company, recently received multiple analyst downgrades in December, causing a cool market reaction. Despite the downgrades, the company has shown resilience and is confident in its future prospects.

The Principal Financial Group Inc., a renowned investment management firm, has purchased shares of Biogen Inc. on the NASDAQ stock exchange. This move showcases Principal Financial Group's confidence in the company's long-term growth potential.

With the recent downgrades, Biogen Inc. is facing challenges, but the company remains focused on delivering innovative treatments for patients. Biogen continues to focus on its pipeline of novel therapies for neurological and autoimmune diseases.

To assess the future movement of Biogen Inc.'s shares, it is recommended to consult professionals from Stocks Prognosis. These experts can provide valuable insights and forecasts based on their in-depth knowledge of the market.

Investors are advised to stay informed and make informed decisions by seeking expert advice. Biogen Inc. is determined to overcome the challenges and emerge stronger in the biotechnology industry.
If you want to leave a comment, then you need Login or Register





Other data for BIIB

Related data

BIIBSeptember 11, 2025Biogen Inc. Stock Price Target Forecast Achieved with 12.88% Profit  ~1 min.

Biogen Inc. (BIIB) investors celebrated as the stock hit the long forecasted price target of 148.84 $ on September 11, 2025, marking a profitable outcome of 12....


BIIBSeptember 11, 2025Biogen Inc. Hits Price Target Forecast with 14.68% Profit  ~1 min.

Amidst recent market volatility, Biogen Inc. has successfully achieved the price target forecast set by QuantWave, resulting in a substantial profit of 14.68%....


BIIBSeptember 11, 2025QuantWave Achieves 14.18% Profit on Biogen Inc. Stock Price Target Forecast  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for Biogen Inc., resulting in a profitable return of 14.18%....


BIIBSeptember 11, 2025Biogen Inc. Stock Price Reaches Forecast Target with 11.82% Profit - QuantWave Success  ~2 min.

Biogen Inc. (NASDAQ: BIIB) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 11.82%. The forecast signal was issued on July 14, 2025, with a price of $133....


BIIBSeptember 11, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 9.98% Profit  ~1 min.

Biogen Inc. investors rejoice as the stock hits the price target forecast set by QuantWave, yielding a profitable return of 9.98%. The forecast signal was initiated on July 10, 2025, with a price of $135....


BIIBSeptember 11, 2025Biogen Inc. Stock Hits Price Target Forecast with 13.92% Profit Gain  ~1 min.

Biogen Inc. has achieved the price target forecast set by QuantWave, signaling a long position on June 13th when the stock was at 130.65 $. The target price of 148....


BIIBSeptember 9, 2025Biogen Inc. Stock Forecast Hits Target with 9.58% Profit - QuantWave Achieves Success in Predictive Analytics  ~1 min.

Biogen Inc. stock has recently achieved a significant price target forecast, as predicted by QuantWave's automated forecasting platform. The forecast signal was given on June 16, 2025, with a price of $131....


BIIBSeptember 9, 2025Biogen Inc. Stock Hits Price Target Forecast, Generating 10.35% Profit for Investors  ~1 min.

Biogen Inc. has successfully achieved the price target forecast set by QuantWave, indicating a profitable opportunity for investors who followed the prediction....


BIIBSeptember 3, 2025Biogen Inc. Stock Hits Price Target Forecast for 11.9% Profit: A Success for QuantWave Analytics  ~1 min.

Biogen Inc. stock recently achieved a price target forecast set by QuantWave, resulting in a profit of 11.9%. The forecast signal was given on June 17, 2025, with the stock priced at $126....


BIIBAugust 24, 2025AIA Group Ltd Makes New 663000 Investment in Biogen Inc. NASDAQ:BIIB  ~1 min.

AIA Group Ltd has recently made a significant investment in Biogen Inc., acquiring 663000 shares on the NASDAQ....


AMGNNovember 24, 2024Amgen Inc. Continues to Lead in Immunotherapy: Experts Recommend Investing in Stocks Prognosis  ~2 min.

Amgen Inc. (NASDAQ: AMGN) has established itself as a frontrunner in immunotherapy research and development, making it a promising investment opportunity for shareholders....


AMGNDecember 26, 2024Amgen Inc. Continues to Attract Investors: Promising Outlook for AMGN  ~2 min.

Leading biotechnology company Amgen Inc. (NASDAQ:AMGN) has caught the attention of investors with its solid performance and positive market trends. In recent news, Principal Financial Group Inc....


AMGNDecember 15, 2024Amgen Inc. Announces Strong Q2 Earnings: Here's What You Need to Know  ~2 min.

Amgen Inc., a leading biotechnology company, has reported strong financial results for the second quarter of 2025. The company's revenue reached a record high of $7....


ABBVNovember 24, 2024AbbVie Inc. Offers Exciting Investment Opportunity After Recent Pullback  ~1 min.

AbbVie Inc. (NYSE: ABBV), a leading pharmaceutical company, has recently experienced a pullback in its stock price, making it an attractive investment opportunity....


JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....